United States: CMS Unveils New Mandatory Medicare Bundled Payment Models For Cardiac & Hip Fracture Cases, Plus Proposed Refinements To CJR Program

On July 25, 2016, CMS announced ambitious, multi-pronged plans to expand mandatory Medicare coordinated care/bundled payment programs, promote the use of cardiac rehabilitation services, refine current Comprehensive Care for Joint Replacement Model (CJR) rules, and integrate bundled payment programs into the upcoming Medicare physician quality/payment framework. The proposed "Advancing Care Coordination through Episode Payment Model" rule is part of the Administration's efforts to move the Medicare system away from fee-for-service (FFS) payments and towards alternative payment models that reward quality of care rather than volume of services.

The new policies are set forth in a 906-page proposed rule that is scheduled to be published in the Federal Register on August 2, 2016. Comments on the rule will be accepted for 60 days from the date of publication.

The following are the major components of the proposed rule; Reed Smith is preparing a more detailed analysis of the program.

New Mandatory Episode Payment Models for Cardiac Care, Hip Fractures

CMS proposes to test three new Medicare Parts A and B bundled payment models – which it calls "episode payment models" (EPMs) – for episodes of care surrounding an acute myocardial infarction (AMI), coronary artery bypass graft (CABG), and surgical hip/femur fracture treatment excluding lower extremity joint replacement (SHFFT). The goal for the proposed EPMs is to improve the quality of care provided to beneficiaries in an applicable episode while reducing episode spending through financial accountability. Like the CJR program on which these models are patterned, participation in the new EPMs would be mandatory in selected geographic areas. CMS expects the EPMs to result in Medicare savings of $170 million over five years.

CMS proposes to test the proposed EPMs for five performance years (PYs), beginning July 1, 2017 and ending December 31, 2021. Under the proposed rule, CMS would designate 98 randomly-selected metropolitan statistical areas (MSAs) for the CABG and AMI EPMs. CMS plans to test the SHFFT EPM in the same 67 MSAs in which CJR is currently operating.

Under the proposed EPMs, an AMI, CABG, or SHFFT model episode would begin with an inpatient admission to an "anchor hospital" for a specified Medicare Severity-Diagnosis Related Group (MS-DRG):

AMI episodes: AMI MS-DRGs 280-282 and Percutaneous Coronary Intervention (PCI) MS-DRGs 246-251 representing IPPS admissions for AMI that are treated with PCIs

CABG episodes: MS-DRGs 231-236

SHFFT episodes: MS-DRGs 480-482

The episode would end 90 days after the date of discharge. The episode would include the inpatient stay and all related care covered under Medicare Parts A and B within the 90 days after discharge, including hospital care, post-acute care, and physician services, with very limited exceptions.

As under the current CJR program, the acute care hospital would be the "episode initiator" and bear financial risk under the proposed EPMs. During the duration of the program, CMS would continue to pay hospitals and other providers and suppliers according to the usual Medicare FFS rules. At the completion of a PY, CMS would compare (1) actual Medicare claims data for service furnished to beneficiaries during the episode, to (2) a quality-adjusted target price based on historical data with various adjustments with a discount to reflect savings to Medicare. The target price initially would be based on a blend of hospital-specific and regional historical data, transitioning to only regional data for PY4 and PY5. Hospitals that deliver care for less than the quality-adjusted target price and meet applicable quality standards would be eligible for a "reconciliation payment"; hospitals with costs that exceed the quality-adjusted target price would be required to repay Medicare after a phase-in period beginning in the second quarter of PY2. A number of other factors also would be considered in determining reconciliation and repayment amounts, including quality scores, certain transfers and readmissions of beneficiaries to inpatient hospitals for these episodes and various limits on the hospital gains and losses during reconciliation. The following is the phase-in schedule, with limits on repayments and gains:

Repayment Limits (payments from hospital to Medicare):

  • July 2017 – March 2018 (PY1 and quarter 1 of PY2): No repayment
  • April 2018 – December 2018 (quarters 2 through 4 of PY2): Capped at 5 percent
  • 2019 (PY3): Capped at 10 percent
  • 2020 – 2021 (PY4 and PY5): Capped at 20 percent

Reconciliation Payment Limits (payments from Medicare to hospitals):

  • July 2017 – December 2018 (PY1 and PY2): Capped at 5 percent
  • 2019 (PY3): Capped at 10 percent
  • 2020 – 2021 (PY4 and PY5): Capped at 20 percent

As under the CJR program, CMS anticipates that EPM participant hospitals will enter into gainsharing arrangements with other providers and suppliers. Moreover, CMS proposes to add other hospitals as potential collaborators, along with accountable care organizations (ACOs). CMS also proposes to provide hospitals with additional utilization and spending data to help improve care coordination. The proposed rule discusses the extent to which CMS will waive certain Medicare program rules to promote coordination of care. While some policies, such as telehealth originating site requirements, would be waived for all three proposed EPMs, CMS proposes to make model-specific decisions about other waivers, including waivers of the skilled nursing facility 3-day stay requirement and post-discharge nursing visit limits.

Cardiac Rehabilitation Model

CMS also proposes to establish a Cardiac Rehabilitation (CR) incentive payment model to test the use of CR and intensive cardiac rehabilitation (ICR) services for beneficiaries hospitalized for treatment of an AMI or CABG for 90 days post-hospital discharge. CMS proposes to make the CR incentive payments available to hospital participants in 45 geographic areas that were selected for the CABG and AMI EPMs and 45 geographic areas that were not selected for the EPM program. The CR model will span the same five-year period as the cardiac care EPMs.

CMS proposes to make standard Medicare payments for CR/ICR services (HCPCS codes 93797, 93798, G0422, and G0423) at the time of service, with an additional retrospective payment to participant hospitals based on total CR service use:

  • CMS would make an initial payment of $25 per CR/ICR service for each of the first 11 CR/ICR services paid for by Medicare during an AMI or CABG model episode or an AMI or CABG care period.
  • After 11 CR/ICR services are paid for by Medicare for a beneficiary, the level of the per-service CR incentive amount would increase to $175 per CR/ICR service for each additional CR/ICR service paid for by Medicare during the AMI or CABG model episode or AMI care period or CABG care period.

CMS proposes certain limits on services and conditions of coverage for such services.

CMS estimates a total aggregate impact between $27 million in net Medicare costs and $32 million in net Medicare savings from July 2017-December 2024 as a result of the CR incentive payment model; CMS notes that this range of potential impacts is due to uncertainty regarding the extent to which CR/ICR utilization will increase based on the proposed CR incentive.

Integration of Bundled Payment Models within MACRA Physician Quality Payment Program

CMS proposes that physician collaboration with hospitals participating in the new cardiac care and hip fracture EPMs (along with the ongoing CJR program) could qualify as participation in an Advanced Alternative Payment Model (APM) for purposes of the Medicare Access and CHIP Reauthorization Act (MACRA) physician payment and quality reform provisions, beginning in 2018. CMS proposes different rules for the Advanced APM "track," including use of certified health information technology functions and assumption of financial risk.

Revisions to CJR Rules

The proposed rule includes a number of changes to CJR program rules, including: enabling the CJR model to potentially qualify as an Advanced APM; allowing ACOs, critical access hospitals, and hospitals to be CJR collaborators; and other provisions related to financial arrangements, pricing, the reconciliation process, and composite scoring. CMS estimates that the proposed changes in the CJR model will increase estimated costs to the Medicare program by $35 million over the duration of the CJR (April 2016-December 2020) compared to CMS's estimate in the CJR final rule.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.